Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Cushing Syndrome and PDE11A[original query] |
---|
Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer research 2006 Dec 66 (24): 11571-5. Horvath Anelia, Giatzakis Christoforos, Robinson-White Audrey, Boikos Sosipatros, Levine Elizabeth, Griffin Kurt, Stein Erica, Kamvissi Virginia, Soni Payal, Bossis Ioannis, de Herder Wouter, Carney J Aidan, Bertherat Jérôme, Gregersen Peter K, Remmers Elaine F, Stratakis Constantine |
Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jun 14 (12): 4016-24. Libé Rossella, Fratticci Amato, Coste Joel, Tissier Frédérique, Horvath Anelia, Ragazzon Bruno, Rene-Corail Fernande, Groussin Lionel, Bertagna Xavier, Raffin-Sanson Marie Laure, Stratakis Constantine A, Bertherat Jéro |
Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. European journal of endocrinology / European Federation of Endocrine Societies 2009 Jul 161 (1): 153-61. Bimpaki Eirini I, Nesterova Maria, Stratakis Constantine |
Alterations of Phosphodiesterases in Adrenocortical Tumors. Frontiers in endocrinology 2016 7 111. Hannah-Shmouni Fady, Faucz Fabio R, Stratakis Constantine |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: